Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of CJ-30001 and CJ-30002 in Type 2 Diabetes Mellitus Patients [Phase 3]

View source ↗

Summary

A Phase 3 trial update reporting completion of a study evaluating CJ-30001 and CJ-30002 in patients with Type 2 diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• CJ-30001
• CJ-30002

Snippet

Sponsor: HK inno.N Corporation | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED